10 Best Healthcare Stocks to Buy for the Long Term 

7. Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Number of Hedge Fund Holders: 37

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the best healthcare stocks to buy for the long term. Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) announced financial results for fiscal Q1 2026 on May 7, reporting net product revenue of $215.4 million for the quarter, delivering 17% year‑over‑year growth, and on track for full year 2026 net revenues of over $1 billion. Management stated that performance in the quarter highlighted continued strong demand, offset by market access headwinds that are observed every Q1 and were especially “pronounced” this year. In addition, the cost of product sold was $44.5 million, or 20.7% as a percentage of net product revenue, as compared to $32.0 million, or 17.3%, for the prior year period, reflecting a 39% increase.

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) further stated that it is continuing to vigorously protect WAKIX IP into 2030 and filed a suit against AET Pharma/Sandoz regarding the infringement of the amorphous pitolisant patent. The company also received FDA approval of pediatric cataplexy indication on February 13th, and the commercial team initiated full promotional efforts immediately upon approval.

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is a commercial-stage pharmaceutical company that develops and commercializes therapies to treat neurological disorders. Its product, WAKIX, is a molecule that increases histamine signaling in the brain by binding to H3 receptors.